Evidence suggests that psilocybin-assisted therapy for those who have not responded to standard interventions may be beneficial.
Publication|Articles|November 22, 2024
- Fall 2024
- Volume 18
- Issue 02
Fall 2024 Quiz: Test Your Pharmacy Knowledge!
This quiz was created in collaboration with PTCE™.
Advertisement
What was the first massed produced commercial drug?
Articles in this issue
almost 2 years ago
Pharmacy Students Using TikTok to Take Learning to the Next Levelalmost 2 years ago
Q&A: Reducing Mental Health Stigma Starts in Pharmaciesalmost 2 years ago
Half of Pharmacy Technicians Feel Fulfilled in Their Current Rolealmost 2 years ago
Student Exchange Program Crafts Cultural Competency for Pharmacistsalmost 2 years ago
Overcoming Failure as a Recent Pharmacy Graduatealmost 2 years ago
Technology in the Classroom Helps Shape Tomorrow’s Pharmacy Leadersalmost 2 years ago
Staying in the Know: Pharmacists, Drug Shortages, and What Lies Aheadalmost 2 years ago
Understanding the Burnout Crisis Among Student Pharmacistsalmost 2 years ago
Pharmacist Provider Status Is Growing. Now What?Advertisement
Related to this article
Investigational antiamyloid monoclonal antibodies may offer a novel pathway to disease reversal.
Increasingly, pharmacists are leading the obesity management team.
A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.
Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.
The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Phase 2 MILESTONE results suggest that postinduction minimal residual disease (MRD) negativity can identify a small subset of transplant-eligible patients with newly diagnosed multiple myeloma who may defer autologous stem cell transplantation.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Belzutifan Plus Lenvatinib for Advanced Renal Cell Carcinoma After Immunotherapy
2
After 180 Years, Multiple Myeloma Gets a Definition of Cure
3
FDA Approves Insulin Efsitora, Once-Weekly Basal Insulin Injection for Adults With T2D
4
Severe Asthma's Effects May Extend Beyond the Lungs, Brain Imaging Study Suggests
5